BioMAdvanced Diagnostics is a developer of molecular diagnostic and biomarker tests.
BioMAdvanced Diagnostics has raised $1.6M in total funding. The most recent round was Venture - Series Unknown. The last funding was announced in July 2023.
BioMAdvanced Diagnostics's investors include Bpifrance, Pays de la Loire Participations, Sodero Gestion, Atlantique Vendée Innovation.
BioMAdvanced Diagnostics is headquartered in Nantes, France.
BioMAdvanced Diagnostics is a developer of molecular diagnostic and biomarker tests.
BioMAdvanced Diagnostics is at the Venture - Series Unknown stage.
Free to use in articles, research, and reference works. Stable URL — will not change. Data on this page last updated .
"BioMAdvanced Diagnostics — Funding & Investors." VCBacked, July 14, 2023, https://www.vcbacked.co/company/biomadvanced-diagnostics. Accessed September 30, 2026.
VCBacked. (2023). BioMAdvanced Diagnostics — Funding & Investors. Retrieved September 30, 2026, from https://www.vcbacked.co/company/biomadvanced-diagnostics
{{cite web |title=BioMAdvanced Diagnostics — Funding & Investors |url=https://www.vcbacked.co/company/biomadvanced-diagnostics |website=VCBacked |access-date=September 30, 2026}}Profile data sourced and verified per the VCbacked methodology · Last funding round dated